Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, China.
Department of Endocrinology, Beijing Key Laboratory of Diabetes Research and Care, Center for Endocrine Metabolism and Immune Diseases, Lu He Hospital, Capital Medical University, Beijing, China.
J Gastroenterol Hepatol. 2020 Sep;35(9):1524-1531. doi: 10.1111/jgh.15004. Epub 2020 Feb 19.
No predictive model for lymph node metastasis (LNM) of superficial esophagogastric junction (EGJ) cancer exists. This study aimed to evaluate incidence, identify risk factors, and develop a predictive nomogram for LNM in patients with superficial EGJ cancers.
Data were extracted from the Surveillance, Epidemiology, and End Results database for model development and internal validation. Another data set was obtained from two hospitals for external validation. A nomogram was developed based on independent risk factors that resulted from a multivariate logistic regression analysis. Internal and external validations were performed to assess the performance of nomogram model by receiver operating characteristic and calibration plot.
Prevalence of LNM was 11.41% for intramucosal cancer and increased to 26.50% for submucosal cancer. On the multivariate analysis, large tumor size (odds ratio [OR] = 1.42; P < 0.001), moderately and poorly/un-differentiated pathological type (OR = 5.62 and 7.67; P = 0.024 and 0.008, respectively), and submucosal invasion (OR = 2.73; P = 0.004) were independent risk factors of LNM. The nomogram incorporating these three predictors demonstrated good discrimination (area under the estimated receiver operating characteristic curve [AUC]: 0.74; 95% confidence interval [95%CI]: 0.68, 0.80) and calibration (mean absolute error was 0.012). Moreover, the discrimination in the internal and external validation sets was good (AUC: 0.73 [95%CI: 0.66, 0.81] and 0.74 [95%CI: 0.60, 0.89], respectively). Nomogram provided better clinical usefulness as assessed by a decision curve analysis.
Prevalence of LNM in superficial EGJ cancer was high. The first risk-predictive nomogram model for LNM of superficial EGJ cancer may help clinicians to decide optimal treatment option preoperatively.
目前尚不存在预测早期食管胃交界部(EGJ)癌淋巴结转移(LNM)的模型。本研究旨在评估 LNM 的发生率,确定风险因素,并为早期 EGJ 癌患者建立 LNM 的预测列线图。
本研究从监测、流行病学和最终结果(SEER)数据库中提取数据用于模型的建立和内部验证,从另外两个医院获得的数据集用于外部验证。基于多变量逻辑回归分析的独立危险因素建立列线图。通过接受者操作特征曲线和校准图对内、外部验证来评估列线图模型的性能。
黏膜内癌的 LNM 发生率为 11.41%,黏膜下癌的 LNM 发生率增加至 26.50%。多变量分析显示,肿瘤较大(比值比 [OR] = 1.42;P < 0.001)、中度和低分化/未分化病理类型(OR = 5.62 和 7.67;P = 0.024 和 0.008)以及黏膜下浸润(OR = 2.73;P = 0.004)是 LNM 的独立危险因素。纳入这三个预测因素的列线图具有良好的区分度(估计接受者操作特征曲线下面积 [AUC]:0.74;95%置信区间 [95%CI]:0.68,0.80)和校准(平均绝对误差为 0.012)。此外,内部和外部验证集的区分度较好(AUC:0.73 [95%CI:0.66,0.81] 和 0.74 [95%CI:0.60,0.89])。决策曲线分析显示,列线图具有更好的临床实用性。
早期 EGJ 癌 LNM 发生率较高。首个预测早期 EGJ 癌 LNM 的风险预测列线图模型可能有助于临床医生术前选择最佳治疗方案。